South Rampart Pharma Appoints Robert Dickey, MBA, as Chief Financial Officer

Mr. Dickey brings over 25 years of experience as a CFO and COO in private, public, and revenue stage companies with deep capital markets and business development transactional expertise across life science

Related Keywords

Jenene Thomas ,Daiichi Sankyo ,Rob Dickey ,Robert Dickey ,Sloan Kettering ,Hernan Bazan ,Caladrius Biosciences ,Kostenloser Wertpapierhandel ,Linkedin ,Twitter ,Locus Pharmaceuticals ,Audit Committee ,Lehman Brothers ,Protarga Inc ,Wharton School ,Emmaus Life Sciences ,Facebook ,Foresite Advisors ,Princeton University ,Corporate Company Contact ,Leadership Team At Cell One Partners ,Board Of Angiogenex Inc ,Corporate Development ,University Of Pennsylvania ,South Rampart Pharma ,Chief Financial ,Chief Executive Officer ,South Rampart ,Chief Financial Officer ,Tyme Technologies ,Audit Committee Chair ,Angiogenex Inc ,Memorial Sloan Kettering ,Chief Corporate Development Officer ,Leadership Team ,Cell One ,Rampart Pharma ,Company Contact ,South ,Rampart ,Dharma ,Ppoints ,Robert ,Mickey ,Chief ,Financial ,Officer ,